Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum–Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial

BACKGROUND: We confirmed the safety of postoperative bio-chemoradiotherapy using cetuximab and docetaxel in a small number of patients with cis-platinum–intolerant core high-risk head and neck cancer. OBJECTIVE: To assess treatment efficacy, we planned a phase 2 study of postoperative bio-chemoradio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Goshi, Hatakeyama, Hiromitsu, Shiono, Osamu, Taguri, Masataka, Komatsu, Masanori, Sano, Daisuke, Sakuma, Naoko, Yabuki, Kenichiro, Arai, Yasuhiro, Shibata, Kunihiko, Chiba, Yoshihiro, Tanabe, Teruhiko, Oridate, Nobuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2018
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127497/
https://www.ncbi.nlm.nih.gov/pubmed/30139721
http://dx.doi.org/10.2196/11003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127497/
https://www.ncbi.nlm.nih.gov/pubmed/30139721
http://dx.doi.org/10.2196/11003

Ejemplares similares